volume 20, issue 4, P931-961 2006
DOI: 10.1016/j.idc.2006.09.001
View full text
|
|
Share

Abstract: Until recently, inflammatory diseases, collagen vascular diseases, inflammatory bowel diseases, and multiple sclerosis were met with a limited offering for treatment. The introduction of biologic agents has revolutionized the approach to these diseases, offering many patients freedom from disease activity staving off resultant destruction to organs and joints with marked improvement in quality of life and disability. This article focuses on the development of serious infections associated with the use of biolo…

expand abstract